# Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease

> **NCT01541579** · PHASE3 · COMPLETED · sponsor: **Tigenix S.A.U.** · enrollment: 278 (estimated)

## Conditions studied

- Crohn's Disease

## Interventions

- **OTHER:** Cx601
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT01541579
- **Lead sponsor:** Tigenix S.A.U.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-07
- **Final completion:** 2016-11
- **Target enrollment:** 278 (ESTIMATED)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541579, "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01541579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*